The effect of RPL39 on pancreatic cancer cell apoptosis seems to be dependent on caspase 8 activation suggesting that targeting RPL39 could be a potential treatment in pancreatic cancer [105]. The gene discussed is CASP8; the disease is familial pancreatic carcinoma.